SOPHiA GENETICS, Laboratorio Curie partner for BRCA gene mutations detection
Under the partnership, Laboratorio Curie will use the SOPHiA DDM Platform technology to deploy a new test for…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Sep 23
Under the partnership, Laboratorio Curie will use the SOPHiA DDM Platform technology to deploy a new test for…
14 Sep 23
The decision to discontinue the trial was based on the recommendation of the Data Safety Monitoring Board (DSMB)…
14 Sep 23
Investment will support rapid growth of Sempre's life sciences and payer networks and expansion into adjacent product areas
14 Sep 23
The companies will work together to promote the Devyser laboratory services to support and advance research and development…
13 Sep 23
The exclusive licensing partnership agreement provides Astellas with a total of up to €5.5m, in upfront and milestone…
13 Sep 23
Under the partnership, both firms will develop a range of digitally discovered and automatically synthesised molecules on Chemify's…
13 Sep 23
The money raised from the Series B extension will be used by ROME to advance its LINE-1 reverse…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 Sep 23
Through the acquisition, the French firm adds VERT-002, a monoclonal antibody that targets and degrades c-MET, which is…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 Sep 23
The collaboration aims to expedite the development of an immuno-oncology product designed to treat specific cancers
13 Sep 23
SEQUENCE, a Phase 3 head-to-head study (study drug open-label and efficacy assessment blinded) compared risankizumab to ustekinumab for…